GENOMIC HEALTH INC's ticker is GHDX and the CUSIP is 37244C101. A total of 1 filers reported holding GENOMIC HEALTH INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $74,000 | +27.6% | 1,107 | +10.7% | 0.00% | – |
| Q2 2019 | $58,000 | -28.4% | 1,000 | -14.4% | 0.00% | – |
| Q1 2019 | $81,000 | +9.5% | 1,168 | 0.0% | 0.00% | – |
| Q4 2018 | $74,000 | +48.0% | 1,168 | +16.8% | 0.00% | – |
| Q2 2018 | $50,000 | +47.1% | 1,000 | 0.0% | 0.00% | – |
| Q1 2018 | $34,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q4 2017 | $34,000 | +6.2% | 1,000 | 0.0% | 0.00% | – |
| Q3 2017 | $32,000 | +3.2% | 1,000 | 0.0% | 0.00% | – |
| Q2 2017 | $31,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q1 2017 | $31,000 | +6.9% | 1,000 | 0.0% | 0.00% | – |
| Q4 2016 | $29,000 | +3.6% | 1,000 | 0.0% | 0.00% | – |
| Q3 2016 | $28,000 | +7.7% | 1,000 | -4.4% | 0.00% | – |
| Q2 2016 | $26,000 | 0.0% | 1,046 | -5.3% | 0.00% | – |
| Q1 2016 | $26,000 | -29.7% | 1,104 | +4.3% | 0.00% | – |
| Q4 2015 | $37,000 | +3600.0% | 1,058 | +1724.1% | 0.00% | – |
| Q3 2015 | $1,000 | – | 58 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 13,770,982 | $433,648,000 | 3.55% |
| Camber Capital Management LP | 2,458,100 | $77,406,000 | 3.14% |
| EMORY UNIVERSITY | 76,851 | $2,420,000 | 2.28% |
| Tributary Capital Management, LLC | 294,962 | $9,288,000 | 0.91% |
| Motley Fool Asset Management LLC | 131,935 | $4,155,000 | 0.90% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 1,607,649 | $50,625,000 | 0.71% |
| UNIVERSITY OF NOTRE DAME DU LAC | 79,693 | $2,510,000 | 0.63% |
| Motley Fool Wealth Management, LLC | 129,245 | $4,070,000 | 0.39% |
| Spark Investment Management LLC | 189,700 | $5,973,000 | 0.38% |
| TFS CAPITAL LLC | 35,026 | $1,103,000 | 0.36% |